Clinical trial
Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in…
NCT00413751 · Walter Reed Army Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00413751 |
|---|---|
| Title | Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes |
| Lead sponsor | Walter Reed Army Medical Center, U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) |
| Enrollment | 20 |
| First posted | Dec 20, 2006 |
| Last update posted | Dec 20, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: